MedPath

Effects of Coffee Roasting on Blood Sugar Levels in Healthy Humans

Not Applicable
Completed
Conditions
Hyperglycemia
Registration Number
NCT05119153
Lead Sponsor
North Carolina State University
Brief Summary

The present study determined the effects light, medium, and dark roasted, brewed coffees on blood glucose responses in normal (n = 19) subjects.

Detailed Description

This is a single-blinded, randomized partial block design conducted over 6 weeks in two parts.

In part 1 (3 weeks), participants were randomly assigned to consume four beverages: a placebo containing water and caramel color, light, medium, or dark roast coffee before, during, or after consumption of a beverage containing 50 g of glucose.

In part 2 (3 weeks), participants were randomly assigned to consume four beverages: a placebo containing water and caramel color, light, medium, or dark roast coffee before, during, or after consumption of a standardized breakfast (corn flakes cereal + skim milk) containing 50 g of glucose.

In each part, fasting and postprandial glucose profiles were determined.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
19
Inclusion Criteria

β€’ Age 18-64 years old with BMI less than 29 and fasting blood glucose less than 125 mg/dl.

Exclusion Criteria
  • Age 18-64 years old with BMI less than 29 and fasting blood glucose less than 125 mg/dl.

  • Weight less than 110 pounds (55 kg)

  • Pre-existing health conditions, such as:

    • High cholesterol
    • Hypertension
    • Cardiovascular disease
    • Gastrointestinal motility disorders
    • Hypo- or hyperthyroidism
    • Anemia
    • Renal disease
    • Liver disease, including hepatitis B or C, cholestasis, cirrhotic liver disease, or non-alcoholic fatty liver disease
    • Chronic or acute pancreatitis
    • Diabetes type 1 or 2
    • Insulin resistance
    • Polycystic ovary syndrome
  • Food allergies or intolerances to coffee/caffeine/dairy/corn-based cereals.

  • Currently taking prescription medication

  • Current smoker

  • Consumes more than 3 alcoholic beverages per day

  • Pregnant or breastfeeding

  • Not willing to take their own blood samples with finger sticks

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Changes in Blood Glucose6 weeks

Each week, fasted baseline and postprandial measurements taken out to 240 minutes

Secondary Outcome Measures
NameTimeMethod
Changes in Glucose Area Under the Curve6 weeks

Used glucose changes over 240 minutes to construct area under the curve

Trial Locations

Locations (1)

Schaub Hall, Campus Box 7624

πŸ‡ΊπŸ‡Έ

Raleigh, North Carolina, United States

Schaub Hall, Campus Box 7624
πŸ‡ΊπŸ‡ΈRaleigh, North Carolina, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.